Newsroom

Recent News Releases

September 19, 2022 9/19/2022

Takeda Signs Virtual Power Purchase Agreement with Enel North America to Advance Renewable Energy Production in the United States

September 16, 2022 9/16/2022

Takeda Receives Positive CHMP Opinion for Maribavir for the Treatment of Adults with Post-transplant Cytomegalovirus (CMV) Refractory (With or Without Resistance) to Prior Therapies

September 13, 2022 9/13/2022

Takeda Selects New Partners for Global Corporate Social Responsibility (CSR) Program to Strengthen Health Systems in Low- and Middle-Income Countries

August 22, 2022 8/22/2022

Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved in Indonesia for Use Regardless of Prior Dengue Exposure

July 28, 2022 7/28/2022

Takeda Delivers Strong First Quarter FY2022 Results; On Track Towards Full-Year Management Guidance

SEE ALL NEWS AND RELEASES >

・For Shire news releases, click here

Featured Topics

Luck is not a strategy: The world needs to start preparing now for the next pandemic

Learn more

The COVID-19 Mental Burden on Working Mothers

Learn more

Takeda Neuroscience at the Annual Meeting of the American Academy of Neurology (AAN) 2021

Learn more

Takeda Breaks Ground on Commercial Cell Therapy Manufacturing Facility in Lexington, Massachusetts

Learn more

Spotlight Malawi: Many Paths Towards Universal Health Coverage and a Strong Health Workforce

Learn more

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.